Skip to main content

Advertisement

SpringerLink
Log in

Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases

  • Review
  • Published:
Archivum Immunologiae et Therapiae Experimentalis Aims and scope

Abstract

Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the main autoimmune cholestatic liver diseases. IgG4-associated sclerosing cholangitis is another distinct immune-mediated cholestatic disorder of unknown aetiology that is frequently associated with autoimmune pancreatitis or other IgG4-related diseases. Although the majority of PBC and PSC patients have a typical presentation, there are common and uncommon important variants or specific subgroups that observed in everyday routine clinical practice. In this updated review, we summarize the published data giving also our own experience on the variants and specific groups of autoimmune cholestatic liver diseases. Actually, we give in detail the underlining difficulties and the rising dilemmas concerning the diagnosis and management of these special conditions in the clinical spectrum of autoimmune cholestatic liver diseases including the IgG4-associated sclerosing cholangitis highlighting also the uncertainties and the potential new eras of the research agenda.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aabakken L, Karlsen TH, Albert J et al (2017) Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy 49:588–608

    Article  PubMed  Google Scholar 

  • Al Mamari S, Djordjevic J, Halliday JS et al (2013) Improvement of serum alkaline phosphatase to < 1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 58:329–334

    Article  CAS  PubMed  Google Scholar 

  • Al-Chalabi T, Portmann BC, Bernal W et al (2008) Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther 28:209–220

    Article  CAS  PubMed  Google Scholar 

  • Ali AH, Sinakos E, Silveira MG et al (2011) Varices in early histological stage primary biliary cirrhosis. J Clin Gastroenterol 45:e66–e71

    Article  PubMed  Google Scholar 

  • Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938

    Article  CAS  PubMed  Google Scholar 

  • Angulo P, Maor-Kendler Y, Lindor KD (2002) Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35:1494–1500

    Article  PubMed  Google Scholar 

  • Benito de Valle M, Muller T, Bjornsson E et al (2014) The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis. Dig Liver Dis 46:903–908

    Article  CAS  PubMed  Google Scholar 

  • Berntsen NL, Klingenberg O, Juran BD et al (2015) Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis. Gastroenterology 148:924–927

    Article  CAS  PubMed  Google Scholar 

  • Bizzaro N, Covini G, Rosina F et al (2012) Overcoming a “probable” diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Clin Rev Allergy Immunol 42:288–297

    Article  CAS  PubMed  Google Scholar 

  • Bjornsson E (2009) Small-duct primary sclerosing cholangitis. Curr Gastroenterol Rep 11:37–41

    Article  PubMed  Google Scholar 

  • Bjornsson E, Boberg KM, Cullen S et al (2002) Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 51:731–735

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bjornsson E, Olsson R, Bergquist A et al (2008) The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 134:975–980

    Article  PubMed  Google Scholar 

  • Boberg KM, Chapman RW, Hirschfield GM et al (2011) Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374–385

    Article  PubMed  Google Scholar 

  • Bogdanos DP, Liaskos C, Pares A et al (2007) Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology 45:1583–1584

    Article  PubMed  Google Scholar 

  • Boonstra K, Weersma RK, van Erpecum KJ et al (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58:2045–2055

    Article  CAS  PubMed  Google Scholar 

  • Boonstra K, Culver EL, de Buy Wenniger LM et al (2014) Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59:1954–1963

    Article  CAS  PubMed  Google Scholar 

  • Bressler B, Pinto R, El-Ashry D, Heathcote EJ (2005) Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection? Gut 54:407–410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carey EJ, Ali AH, Lindor KD (2015) Primary biliary cirrhosis. Lancet 386:1565–1575

    Article  CAS  PubMed  Google Scholar 

  • Chazouilleres O, Wendum D, Serfaty L et al (1998) Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28:296–301

    Article  CAS  PubMed  Google Scholar 

  • Chazouilleres O, Wendum D, Serfaty L et al (2006) Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 44:400–406

    Article  CAS  PubMed  Google Scholar 

  • Chen HW, Huang HH, Lai CH et al (2013) Hepatitis C virus infection in patients with primary biliary cirrhosis. Ann Hepatol 12:78–84

    Article  PubMed  Google Scholar 

  • Corpechot C, Chretien Y, Chazouilleres O et al (2010) Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53:162–169

    Article  PubMed  Google Scholar 

  • Dahlqvist G, Gaouar F, Carrat F et al (2017) Large-scale characterization study of patients with antimitochondrial antibodies but non established primary biliary cholangitis. Hepatology 65:152–163

    Article  CAS  PubMed  Google Scholar 

  • Dalekos GN, Skopouli FN, Tsianos EV (1995) Primary biliary cirrhosis associated with anticardiolipin syndrome. Eur J Intern Med 6:179–181

    Google Scholar 

  • Dalekos GN, Lygoura V, Gatselis NK (2018) Variants of primary biliary cholangitis: an updated mini-review. J Autoimmune Dis Rheumatol 6:21–28

    Article  Google Scholar 

  • Dalekos GN, Koskinas J, Papatheodoridis GV (2019) Hellenic Association for the Study of the Liver (HASL) clinical practice guidelines: autoimmune hepatitis. Ann Gastroenterol 32:1–23

    PubMed  Google Scholar 

  • de Franchis R (2015) Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 63:743–752

    Article  PubMed  Google Scholar 

  • Deneau MR, El-Matary W, Valentino PL et al (2017) The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology 66:518–527

    Article  CAS  PubMed  Google Scholar 

  • Dinani AM, Fischer SE, Mosko J, Guindi M et al (2012) Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis. Clin Gastroenterol Hepatol 10:682–684

    Article  PubMed  Google Scholar 

  • Doorenspleet ME, Hubers LM, Culver EL et al (2016) Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. Hepatology 64:501–507

    Article  CAS  PubMed  Google Scholar 

  • Dyson JK, De Martin E, Dalekos GN et al (2019) Review article: unanswered clinical and research questions in autoimmune hepatitis: conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther 49:528–536

    Article  PubMed  Google Scholar 

  • European Association for the Study of the Liver (2015) EASL Clinical Practice Guidelines: autoimmune hepatitis. J Hepatol 63:971–1004

    Article  Google Scholar 

  • European Association for the Study of the Liver (2017a) EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67:145–172

    Article  Google Scholar 

  • European Association for the Study of the Liver (2017b) EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67:370–398

    Article  Google Scholar 

  • European Association for the Study of the Liver (2018) EASL Recommendations on treatment of hepatitis C 2018. J Hepatol 69:461–511

    Article  Google Scholar 

  • Eyraud V, Chazouilleres O, Ballot E et al (2009) Significance of antibodies to soluble liver antigen/liver pancreas: a large French study. Liver Int 29:857–864

    Article  CAS  PubMed  Google Scholar 

  • Floreani A, Baragiotta A, Leone MG et al (2003) Primary biliary cirrhosis and hepatitis C virus infection. Am J Gastroenterol 98:2757–2762

    Article  PubMed  Google Scholar 

  • Floreani A, Rizzotto ER, Ferrara F et al (2005) Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 100:1516–1522

    Article  PubMed  Google Scholar 

  • Floreani A, Caroli D, Variola A et al (2011) A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int 31:361–368

    Article  PubMed  Google Scholar 

  • Floreani A, Franceschet I, Cazzagon N et al (2015a) Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 48:192–197

    Article  CAS  PubMed  Google Scholar 

  • Floreani A, Motta R, Cazzagon N et al (2015b) The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Dig Liver Dis 47:432–435

    Article  PubMed  Google Scholar 

  • Fussey SP, Guest JR, James OF et al (1988) Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 85:8654–8658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gabeta S, Norman GL, Liaskos C et al (2007) Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol 27:378–387

    Article  CAS  PubMed  Google Scholar 

  • Gatselis NK, Dalekos GN (2016) Molecular diagnostic testing for primary biliary cholangitis. Expert Rev Mol Diagn 16:1001–1010

    Article  CAS  PubMed  Google Scholar 

  • Gatselis NK, Stefos A, Gioti C et al (2007) Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature. Liver Int 27:280–283

    Article  PubMed  Google Scholar 

  • Gatselis NK, Zachou K, Dalekos GN (2010a) Early primary biliary cirrhosis: a new association with erythema nodosum of unknown origin. Gastroenterol Res Pract 2010:121620

  • Gatselis NK, Zachou K, Papamichalis P et al (2010b) Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis 42:807–812

    Article  PubMed  Google Scholar 

  • Gatselis NK, Zachou K, Norman GL et al (2013) Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity 46:471–479

    Article  CAS  PubMed  Google Scholar 

  • Gatselis NK, Zachou K, Koukoulis GK et al (2015) Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 21:60–83

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gatselis NK, Zachou K, Lygoura V et al (2017) Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece. Eur J Intern Med 42:81–88

    Article  PubMed  Google Scholar 

  • Gershwin ME, Mackay IR, Sturgess A et al (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525–3531

    CAS  PubMed  Google Scholar 

  • Gershwin ME, Selmi C, Worman HJ et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42:1194–1202

    Article  PubMed  Google Scholar 

  • Granito A, Muratori P, Quarneti C et al (2012) Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn 12:65–74

    Article  CAS  PubMed  Google Scholar 

  • Gregorio GV, Portmann B, Karani J et al (2001) Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33:544–553

    Article  CAS  PubMed  Google Scholar 

  • Haldar D, Hirschfield GM (2014) Overlap syndrome: a real syndrome? Clin Liver Dis 3:43–47

    Article  Google Scholar 

  • Halliday JS, Djordjevic J, Lust M et al (2012) A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn’s disease. J Crohns Colitis 6:174–181

    Article  CAS  PubMed  Google Scholar 

  • Harms MH, Lammers WJ, Thorburn D et al (2018) Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome. Am J Gastroenterol 113:254–264

    Article  PubMed  Google Scholar 

  • Hart PA, Topazian MD, Witzig TE et al (2013) Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62:1607–1615

    Article  CAS  PubMed  Google Scholar 

  • Hatzis GS, Fragoulis GE, Karatzaferis A et al (2008) Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren’s syndrome. J Rheumatol 35:2012–2016

    PubMed  Google Scholar 

  • Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176

    Article  PubMed  Google Scholar 

  • Heurgue A, Vitry F, Diebold MD et al (2007) Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol 31:17–25

    Article  PubMed  Google Scholar 

  • Hirschfield GM, Heathcote EJ (2008) Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis 12:323–331

    Article  PubMed  Google Scholar 

  • Hirschfield GM, Dyson JK, Alexander GJM et al (2018) The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 67:1568–1594

    Article  CAS  PubMed  Google Scholar 

  • Huang YQ (2016) Recent advances in the diagnosis and treatment of primary biliary cholangitis. Word J Hepatol 8:1419–1441

    Article  Google Scholar 

  • Iguchi H, Oda M, Yamazaki H et al (2014) Aquaporin-1 is associated with arterial capillary proliferation and hepatic sinusoidal transformation contributing to portal hypertension in primary biliary cirrhosis. Med Mol Morphol 47:90–99

    Article  CAS  PubMed  Google Scholar 

  • Ikeda F, Okamoto R, Baba N et al (2012) Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis. J Gastroenterol Hepatol 27:1320–1328

    Article  CAS  PubMed  Google Scholar 

  • Invernizzi P, Podda M, Battezzati PM et al (2001) Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34:366–372

    Article  CAS  PubMed  Google Scholar 

  • Kamisawa T, Nakazawa T, Tazuma S et al (2019) Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 26:9–42

    Article  PubMed  PubMed Central  Google Scholar 

  • Kanzler S, Bozkurt S, Herkel J et al (2001) Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome). Dtsch Med Wochenschr 126:450–456

    Article  CAS  PubMed  Google Scholar 

  • Karlsen TH, Folseraas T, Thorburn D et al (2017) Primary sclerosing cholangitis—a comprehensive review. J Hepatol 67:1298–1323

    Article  PubMed  Google Scholar 

  • Kuiper EM, Zondervan PE, van Buuren HR (2010) Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 8:530–534

    Article  PubMed  Google Scholar 

  • Lammers WJ, Hirschfield GM, Corpechot C et al (2015) Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology 149:1804–1812

    Article  PubMed  Google Scholar 

  • Lazaridis KN, LaRusso NF (2016) Primary sclerosing cholangitis. N Engl J Med 375:1161–1170

    Article  PubMed  PubMed Central  Google Scholar 

  • Levy C, Zein CO, Gomez J et al (2007) Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 5:803–808

    Article  PubMed  Google Scholar 

  • Levy C, Naik J, Giordano C et al (2014) Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. Clin Gastroenterol Hepatol 12:1398–1405

    Article  CAS  PubMed  Google Scholar 

  • Lewin M, Vilgrain V, Ozenne V et al (2009) Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology 50:528–537

    Article  PubMed  Google Scholar 

  • Liaskos C, Bogdanos DP, Rigopoulou EI et al (2007) Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? J Gastroenterol Hepatol 22:454–455

    Article  PubMed  Google Scholar 

  • Liaskos C, Norman GL, Moulas A et al (2010) Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clin Chim Acta 411:411–415

    Article  CAS  PubMed  Google Scholar 

  • Lindor KD, Kowdley KV, Harrison ME (2015) ACG Clinical Guideline: primary sclerosing cholangitis. Am J Gastroenterol 110:646–659

    Article  CAS  PubMed  Google Scholar 

  • Lindstrom L, Hultcrantz R, Boberg KM et al (2013) Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 11:841–846

    Article  CAS  PubMed  Google Scholar 

  • Liu H, Norman GL, Shums Z et al (2010) PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 35:436–442

    Article  CAS  PubMed  Google Scholar 

  • Lohse AW, Zum Bϋschenfelde KH, Franz B et al (1999) Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 29:1078–1084

    Article  CAS  PubMed  Google Scholar 

  • Lunder AK, Hov JR, Borthne A et al (2016) Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease. Gastroenterology 151(660–669):e4

    Google Scholar 

  • Luth S, Kanzler S, Frenzel C et al (2009) Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. J Clin Gastroenterol 43:75–80

    Article  PubMed  Google Scholar 

  • Maruyama H, Kondo T, Sekimoto T et al (2015) Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology? Eur J Gastroenterol Hepatol 27:321–327

    Article  PubMed  Google Scholar 

  • Mattalia A, Quaranta S, Leung PS et al (1998) Characterization of antimitochondrial antibodies in health adults. Hepatology 27:656–661

    Article  CAS  PubMed  Google Scholar 

  • Mells GF, Pells G, Newton JL et al (2013) Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology 58:273–283

    Article  PubMed  Google Scholar 

  • Mendes F, Lindor KD (2008) Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am 37:479–484

    Article  PubMed  Google Scholar 

  • Metcalf JV, Mitchinson HC, Palmer JM et al (1996) Natural history of early primary biliary cirrhosis. Lancet 348:1399–1402

    Article  CAS  PubMed  Google Scholar 

  • Mieli-Vergani G, Vergani D, Baumann U et al (2018) Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement. J Pediatr Gastroenterol Nutr 66:345–360

    Article  PubMed  Google Scholar 

  • Mitchison HC, Bassendine MF, Hendrick A et al (1986) Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 6:1279–1284

    Article  CAS  PubMed  Google Scholar 

  • Montano-Loza AJ, Carpenter HA, Czaja AJ (2008) Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol 42:1047–1053

    Article  PubMed  Google Scholar 

  • Muratori P, Granito A, Pappas G et al (2009) The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 104:1420–1425

    Article  PubMed  Google Scholar 

  • Muratori P, Efe C, Muratori L et al (2017) Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. Eur J Gastroenterol Hepatol 29:777–780

    Article  CAS  PubMed  Google Scholar 

  • Murillo Perez CF, Goet JC, Lammers WJ et al (2018) Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history. Hepatology 67:1920–1930

    Article  CAS  PubMed  Google Scholar 

  • Nair V, Fischer SE, Adeyi OA (2010) Non-viral-related pathologic findings in liver needle biopsy specimens from patients with chronic viral hepatitis. Am J Clin Pathol 133:127–132

    Article  PubMed  Google Scholar 

  • Nakamura M, Kondo H, Mori T et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45:118–127

    Article  CAS  PubMed  Google Scholar 

  • Nakanuma Y, Hoso M, Mizuno Y et al (1988) Pathologic study of primary biliary cirrhosis of early histologic stages presenting cholestatic jaundice. Liver 8:319–324

    Article  CAS  PubMed  Google Scholar 

  • O’Brien C, Joshi S, Feld JJ et al (2008) Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 48:550–556

    Article  PubMed  Google Scholar 

  • Ohara H, Okazaki K, Tsubouchi H et al (2012) Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19:536–542

    Article  PubMed  Google Scholar 

  • Ohara H, Nakazawa T, Kawa S et al (2013) Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28:1247–1251

    Article  CAS  PubMed  Google Scholar 

  • Ozaslan E, Efe C, Heurgue-Berlot A et al (2014) Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol 12:863–869

    Article  PubMed  Google Scholar 

  • Papamichalis PA, Zachou K, Koukoulis GK et al (2007) The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 4:3

    Article  PubMed  PubMed Central  Google Scholar 

  • Ponsioen CY, Chapman RW, Chazouillères O et al (2016) Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process. Hepatology 63:1357–1367

    Article  PubMed  Google Scholar 

  • Poupon R, Chazouilleres O, Corpechot C et al (2006) Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology 44:85–90

    Article  PubMed  Google Scholar 

  • Ramos-Casals M, Pares A, Jara LJ et al (2005) Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. J Viral Hepat 12:648–654

    Article  CAS  PubMed  Google Scholar 

  • Rigopoulou EI, Dalekos GN (2004) Anti-sp100 antibodies in primary biliary cirrhosis. Scand J Gastroenterol 39:406–407

    Article  CAS  PubMed  Google Scholar 

  • Rigopoulou EI, Dalekos GN (2008) Molecular diagnostics of primary biliary cirrhosis. Expert Opin Med Diagn 2:621–634

    Article  CAS  PubMed  Google Scholar 

  • Rigopoulou EI, Davies ET, Pares A et al (2005) Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54:528–532

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rigopoulou EI, Zachou K, Gatselis NK et al (2013) Primary biliary cirrhosis in HBV and HCV patients: clinical characteristics and outcome. World J Hepatol 5:577–583

    Article  PubMed  PubMed Central  Google Scholar 

  • Rojas CP, Bodicharla R, Campuzano-Zuluanga G et al (2014) Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents. Fetal Pediatr Pathol 33:202–209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schramm C, Eaton J, Ringe KI et al (2017) Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology 66:1675–1688

    Article  PubMed  Google Scholar 

  • Shen M, Zhang F, Zhang X (2009) Pulmonary hypertension in primary biliary cirrhosis: a prospective study in 178 patients. Scand J Gastroenterol 44:219–223

    Article  CAS  PubMed  Google Scholar 

  • Shibata M, Onozuka Y, Morizane T et al (2004) Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture. J Gastroenterol 39:255–259

    Article  PubMed  Google Scholar 

  • Silveira MG, Talwalkar JA, Angulo P et al (2007) Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 102:1244–1250

    Article  PubMed  Google Scholar 

  • Stanich PP, Bjornsson E, Gossard AA et al (2011) Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. Dig Liver Dis 43:309–313

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sundaram S, Kiran S, Mazumdar S et al (2018) Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis. ACG Case Rep J 5:e54

    Article  PubMed  PubMed Central  Google Scholar 

  • Takemoto R, Miyake Y, Harada K et al (2014) Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis. Intern Med 53:1429–1433

    Article  PubMed  Google Scholar 

  • Tanaka A, Tazuma S, Okazaki K et al (2014) Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 21:43–50

    Article  PubMed  Google Scholar 

  • Tanaka A, Tazuma S, Nakazawa T et al (2017) No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan. J Hepatobiliary Pancreat Sci 24:217–225

    Article  PubMed  Google Scholar 

  • Tomizawa M, Shinozaki F, Fugo K et al (2015) Anti-mitochondrial M2 antibody-positive autoimmune hepatitis. Exp Ther Med 10:1419–1422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Trivedi PJ, Hirschfield GM (2012) Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther 36:517–533

    Article  CAS  PubMed  Google Scholar 

  • Turchany JM, Uibo R, Kivik T et al (1997) A study of antimitochondrial antibodies in a random population in Estonia. Am J Gastroenterol 92:124–126

    CAS  PubMed  Google Scholar 

  • Vleggaar FP, van Buuren HR, Zondervan PE et al (2001) Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant. Gut 49:276–281

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140–145

    Article  CAS  PubMed  Google Scholar 

  • Weismuller TJ, Trivedi PJ, Bergquist A et al (2017) Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 152(1975–1984):e8

    Google Scholar 

  • Yang F, Wang Q, Wang Z et al (2016) The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis. Clin Rev Allergy Immunol 50:114–123

    Article  CAS  PubMed  Google Scholar 

  • Zachou K, Liaskos C, Rigopoulou E et al (2006) Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 119:203–212

    Article  CAS  PubMed  Google Scholar 

  • Zachou K, Gatselis NK, Papadamou G et al (2011) Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients. J Hepatol 55:636–646

    Article  CAS  PubMed  Google Scholar 

  • Zachou K, Muratori P, Koukoulis GK et al (2013) Review article: autoimmune hepatitis—current management and challenges. Aliment Pharmacol Ther 38:887–913

    Article  CAS  PubMed  Google Scholar 

  • Zachou K, Gampeta S, Gatselis NK et al (2015) Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis. Liver Int 35:660–672

    Article  CAS  PubMed  Google Scholar 

  • Zachou K, Gatselis NK, Arvaniti P et al (2016) A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis. Aliment Pharmacol Ther 43:1035–1047

    Article  CAS  PubMed  Google Scholar 

  • Zenouzi R, Lohse AW (2014) Long-term outcome in PSC/AIH “overlap syndrome”: does immunosuppression also treat the PSC component? J Hepatol 61:1189–1191

    Article  PubMed  Google Scholar 

  • Zhang H, Li S, Yang J et al (2015) A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations. Prz Gastroenterol 10:148–155

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zografos TA, Gatselis N, Zachou K et al (2012) Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. Word J Gastroenterol 18:4721–4728

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Internal Medicine and Hepatology, Larissa, Greece

    George N. Dalekos & Nikolaos K. Gatselis

  2. Department of Medicine and Research Laboratory of Internal Medicine, University Hospital of Larissa, 41110, Larissa, Greece

    George N. Dalekos & Nikolaos K. Gatselis

Authors
  1. George N. Dalekos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolaos K. Gatselis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George N. Dalekos.

Ethics declarations

Conflict of interest

Authors have nothing to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalekos, G.N., Gatselis, N.K. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases. Arch. Immunol. Ther. Exp. 67, 197–211 (2019). https://doi.org/10.1007/s00005-019-00550-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00005-019-00550-9

Keywords

Search

Navigation